ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,01%
Bitcoin
67.778,82
0,44%
Brent Oil
81,295
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. ContextLogic Inc (LOGC)

  7. ContextLogic Inc (LOGC) Notícias

LOGC

ContextLogic (LOGC)

ContextLogic Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:LOGC
DataHoraFonteTítuloCódigoCompanhia
10/02/202318:40Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LOGCContextLogic Inc
29/11/202218:07Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:LOGCContextLogic Inc
21/11/202208:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LOGCContextLogic Inc
16/11/202218:05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOGCContextLogic Inc
16/11/202218:04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:LOGCContextLogic Inc
16/11/202211:56Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:LOGCContextLogic Inc
16/11/202210:30Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:LOGCContextLogic Inc
16/11/202210:21Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:LOGCContextLogic Inc
14/11/202210:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LOGCContextLogic Inc
14/11/202210:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LOGCContextLogic Inc
14/11/202210:00PR Newswire (US)LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:LOGCContextLogic Inc
20/10/202209:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LOGCContextLogic Inc
18/10/202217:14Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:LOGCContextLogic Inc
18/10/202217:04Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:LOGCContextLogic Inc
13/10/202217:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:LOGCContextLogic Inc
03/10/202217:47Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:LOGCContextLogic Inc
03/10/202212:20Dow Jones NewsLogicBio Therapeutics Shares Soar on Takeover by AstraZenecaNASDAQ:LOGCContextLogic Inc
03/10/202211:50TipRanksAnalysts Offer Insights on Healthcare Companies: Clene (CLNN) and Logicbio Therapeutics (LOGC)NASDAQ:LOGCContextLogic Inc
03/10/202209:19TipRanksAstraZeneca to Buy LogicBio Therapeutics for $2.07 Per ShareNASDAQ:LOGCContextLogic Inc
03/10/202208:57Dow Jones NewsAstraZeneca to Buy LogicBio Therapeutics for $68 MillionNASDAQ:LOGCContextLogic Inc
03/10/202208:15Business WireAlexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic MedicineNASDAQ:LOGCContextLogic Inc
21/09/202209:30PR Newswire (US)LogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONENASDAQ:LOGCContextLogic Inc
18/08/202223:15TipRanksLogicbio Therapeutics (LOGC) Receives a Buy from William BlairNASDAQ:LOGCContextLogic Inc
16/08/202205:55TipRanksJMP Securities Keeps Their Buy Rating on Logicbio Therapeutics (LOGC)NASDAQ:LOGCContextLogic Inc
15/08/202208:05PR Newswire (US)LogicBio Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:LOGCContextLogic Inc
21/06/202209:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LOGCContextLogic Inc
24/05/202206:06TipRanksWilliam Blair Thinks Logicbio Therapeutics’ Stock is Going to RecoverNASDAQ:LOGCContextLogic Inc
18/05/202208:40TipRanksAnalysts Offer Insights on Healthcare Companies: Compugen (CGEN) and Logicbio Therapeutics (LOGC)NASDAQ:LOGCContextLogic Inc
18/05/202201:45TipRanksAnalysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Logicbio Therapeutics (LOGC)NASDAQ:LOGCContextLogic Inc
17/05/202209:30PR Newswire (US)LogicBio® Therapeutics to Present at H.C. Wainwright Global Investment ConferenceNASDAQ:LOGCContextLogic Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:LOGC

Seu Histórico Recente

EU
AUCDL
Amundi Finance Emissions...
NASDAQ
FQEEWX
Core Holdings Growth Tru...
UNSW3
POLKETH
Polkamarkets
BIT
P06576
Vontobel Financial Produ...
COIN
EJOYUSD
NASDAQ
NEWT
NewtekOne
LSE
57GI
07dec2043c
ASX
IPLCD
Incitec Pivot
NASDAQ
FSKHSX
Cboe Vest Nasdaq 100 Buf...
USOTC
TPRKY
Travis Perkins (PK)
TG
65C
Coface
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados